Identification of plasma proteins that are susceptible to thiol oxidation by hypochlorous acid and N-chloramines

Chemical Research in Toxicology

Volumn 21, Issue 9, 2008, Pages 1832-1840

  Summers, Fiona A ^a   Morgan, Philip E ^a   Davies, Michael J ^a   Hawkins, Clare L ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; AMMONIA; CHLORAMINE DERIVATIVE; CHLORIDE ION; DODECYL SULFATE SODIUM; GLYCINE; HISTIDINE; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; LYSINE; MYELOPEROXIDASE; PLASMA PROTEIN; TAURINE; THIOL;

ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS;

ALPHA 1-ANTITRYPSIN; BLOOD PROTEINS; CHLORAMINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; HYPOCHLOROUS ACID; MALE; OXIDANTS; OXIDATION-REDUCTION; PEROXIDASE; REFERENCE VALUES; SULFHYDRYL COMPOUNDS;

EID: 53549122736     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx8001719     Document Type: Article

References (72)

1. Hampton, M. B., Kettle, A. J., and Winterbourn, C. C. (1998) Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 92, 3007-3017.
2. Daugherty, A., Dunn, J. L., Rateri, D. L., and Heinecke, J. W. ( 1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94,437-444.
3. Weiss, S. J. (1989) Tissue destruction by neutrophils. N. Engl. J. Med 320, 365-376.
4. Heinecke, J. W. (1999) Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J. Lab. Clin. Med. 133, 321-325.
5. van der Vliet, A., Nguyen, M. N., Shigenaga, M. K., Eiserich, J. P., Marelich, G. P., and Cross, C. E. (2000) Myeloperoxidase and protein oxidation in cystic fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L537-L546.
6. Gaut, J. P., Yen, G. C.,Tran, H. D., Byun, J., Henderson, J. P., Richter, G. M., Brennan, M. L., Lusis, A. J., Belaaouaj, A., Hotchkiss, R. S., and Heinecke, J. W. (2001 ) Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci. U.S.A. 98, 11961-11966.
7. Schiller, J., Fuchs, B., Arnhold, J., and Arnold, K. (2003) Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways, diagnosis and potential therapeutic strategies. Curr. Med. Chem. 10, 2123-2145.
8. Weitzman, S. A., and Gordon, L. I. (1990) Inflammation and cancer, role of phagocyte-generated oxidants in carcinogenesis. Blood 76, 655-663.
9. Malle, E., Buch, T., and Grone, H. J. (2003) Myeloperoxidase in kidney disease. Kidney Int. 64, 1956-1967.
10. Nicholls, S. J., and Hazen, S. L. (2005) Myeloperoxidase and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 1102-1111.
11. Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., and Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97, 1535-1544.
12. Hazell, L. J., Baernthaler, G., and Stocker, R. (2001) Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radical Biol Med. 31, 1254-1262.
13. Zhang, R., Brennan, M. L., Fu, X., Aviles, R. J., Pearce, G. L., Penn, M. S., Topol, E J., Sprecher, D. L., and Hazen, S. L. (2001) Association between myeloperoxidase levels and risk of coronary artery disease. J. Am. Med Assoc. 286, 2136-2142.
14. Baldus, S., Heeschen, C.,Meinertz, T., Zeiher, A. M., Eiserich, J. P., Munzel, T., Simoons, M. L., and Hamm, C. W. (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108, 1440-1445.
15. Brennan, M. L., Perm, M. S., VanLente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., Nissen, S. E., and Hazen, S. L. (2003) Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349, 1595-1604.
16. Winterbourn, C. C. (2002) Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181-182, 223-227.
17. Pattison, D. I., and Davies, M. J. (2001) Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem. Res. Toxicol. 14, 1453-1464.
18. Thomas, E. L., Grisham, M. B., and Jefferson, M. M. (1986) Preparation and characterization of chloramines. Methods Enzymol. 132, 569-585.
19. Grisham, M. B., Jefferson, M. M., Melton, D. F., and Thomas, E. L. (1984) Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J. Biol. Chem. 259, 10404-10413.
20. Thomas, E. L., Grisham, M. B., and Jefferson, M. M. (1986) Cytotoxicity of chloramines. Methods Enzymol. 132, 585-593.
21. Peskin, A. V., and Winterbourn, C. C. (2001) Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine, and ascorbate. Free Radical Biol. Med. 30, 572-579.
22. Peskin, A. V., and Winterbourn, C. C. (2006) Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase. Free Radical Biol. Med. 40, 45-53.
23. Pattison, D. I., and Davies, M. J. (2005) Kinetic analysis of the role of histidine chloramines in hypochlorous acid mediated protein oxidation. Biochemistry 44, 7378-7387.
24. Arnhold, J., Hammerschmidt, S., and Arnold, K. (1991) Role of functional groups of human plasma and luminol in scavenging of NaOCl and neutrophil-derived hypochlorous acid. Biochim. Biophys. Acta 1097, 145-151.
25. Hu, M. L., Louie, S., Cross, C. E., Motchnik, P., and Halliwell, B. (1993) Antioxidant protection against hypochlorous acid in human plasma. J. Lab. Clin. Med. 121, 257-262.
26. van der Vliet, A., Hu, M., O'Neill, C. A., Cross, C. E., and Halliwell, B. (1994) Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid. J. Lab. Clin. Med. 124, 701-707.
27. Carr, A. C.,Hawkins, C. L., Thomas, S. R., Stocker, R., and Frei, B. (2001) Relative reactivities of N-chloramines and hypochlorous acid with human plasma constituents. Free Radical Biol. Med. 30, 526-536.
28. Pattison, D. I., Hawkins, C. L., and Davies, M. J. (2007) Hypochlorous acid-mediated protein oxidation: How important are chloramine transfer reactions and protein tertiary structure? Biochemistry 46,9853-9864.
29. Weiss, S. J., Klein, R., Slivka, A., and Wei, M. (1982) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70, 598-607.
30. Morris, J. C. (1966) The acid ionization constant of HOC1 from 5 to 35 °C. J. Phys. Chem 70, 3798-3805.
31. 2 solution in the UV). Anal. Biochem. 49, 474-178.
32. Hawkins, C. L., and Davies, M. J. (1998) Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem. J. 332, 617-625.
33. Morgan, P. E., Sturgess, A. D., and Davies, M. J. (2005) Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum. 52, 2069-2079.
34. Hawkins, C. L., and Davies, M. J. (2005) Inactivation of protease inhibitors and lysozyme by hypochlorous acid: Role of side-chain oxidation and protein unfolding in loss of biological function. Chem. Res. Toxicol. 18, 1600-1610.
35. Morgan, P. E., Sturgess, A. D., Hennessy, A., and Davies, M. J. (2007) Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radical Res. 41, 1301-1312.
36. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
37. Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G. M., Carnemolla, B., Orecchia, P., Zardi, L., and Righetti, P. G. (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25, 1327-1333.
38. Saunders, N. F. W., Ng, C.,Raftery, M., Guilhaus, M., Goodchild, A., and Cavicchioli, R. (2006) Proteomic and computational analysis of secreted proteins with type I signal peptides from the Antarctic archaeon Methanococcoides burtonii. J. Proteome Res. 5, 2457-2464.
39. Daniel, W. W. (1987) Biostatistics: A Foundation for Analysis in the Health Sciences, 5th ed., John Wiley & Sons, New York.
40. Baty, J. W., Hampton, M. B., and Winterbourn, C. C. (2002) Detection of oxidant sensitive thiol proteins by fluorescence labeling and two-dimensional electrophoresis. Proteomics 2, 1261-1266.
41. Baty, J. W., Hampton, M. B., and Winterbourn, C. C. (2005) Proteomic detection of hydrogen peroxide sensitive thiol proteins in Jurkat cells. Biochem. J. 389, 785-795.
42. Buchwald, B. M., and Connell, G. E. (1974) Thiol groups of normal human immunoglobulin G. Biochem. J. 137, 281-289.
43. Lentner, C. (1984) Physical chemistry composition of blood hematology somatometric data. In Geigy Scientific Tables (Lentner, C.,Ed.) pp 89-106, Ciba-Geigy Ltd., Basle, Switzerland.
44. Carballal, S., Radi, R., Kirk, M. C.,Barnes, S., Freeman, B. A., and Alvarez, B. (2003) Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 42, 9906-9914.
45. Prutz, W. A., Kissner, R., Nauser, T., and Koppenol, W. H. (2001) On the oxidation of cytochrome c by hypohalous acids. Arch. Biochem. Biophys. 389, 110-122.
46. Peskin, A. V., and Winterbourn, C. C. (2003) Histamine chloramine reactivity with thiol compounds, ascorbate, and methionine and with intracellular glutathione. Free Radical Biol. Med. 35, 1252-1260.
47. Segelmark, M., Persson, B., Hellmark, T., and Wieslander, J. (1997) Binding and inhibition of myeloperoxidase (MPO): A major function of ceruloplasmin? Clin. Exp. Immunol. 108, 167-174.
48. Park, Y. S., Suzuki, K., Mumby, S., Taniguchi, N., and Gutteridge, J. M. (2000) Antioxidant binding of caeruloplasmin to myeloperoxidase: myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact. Free Radical Res. 33, 261-265.
49. Salavej, P., Spalteholz, H., and Arnhold, J. (2006) Modification of amino acid residues in human serum albumin by myeloperoxidase. Free Radical Biol. Med. 40, 516-525.
50. 1- antitrypsin induced by hypohalous acids and the myeloperoxidase-hydrogen peroxide-halide system. Arch. Biochem. Biophys. 459, 137-142.
51. Era, S., Kuwata, K., Imai, H., Nakamura, K., Hayashi, T., and Sogami, M. (1995) Age-related change in redox state of human serum albumin. Biochim. Biophys. Acta 1247, 12-16.
52. 1-antitrypsin phenotypes. Chest 100, 703-708.
53. Johnson, S. M., Wiseman, R. L., Sekijima, Y., Green, N. S., Adamski.Werner, S. L., and Kelly, J. W. (2005) Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses. Acc. Chem. Res. 38, 911-921.
54. Maier, K. L., Matejkova, E., Hinze, H., Leuschel, L., Weber, H., and BeckSpeier, I. (1989) Different selectivities of oxidants during oxidation of methionine residues in the α-1-proteinase inhibitor. FEBS Lett. 250, 221-226.
55. Johnson, D., and Travis, J. (1979) The oxidative inactivation of human α-1 -proteinase inhibitor. Further evidence for methionine at the reactive center. J. Biol. Chem. 254, 4022-4026.
56. Griffiths, S. W., King, J., and Cooney, C. L. (2002) The reactivity and oxidation pathway of cysteine 232 in recombinant human αl-antitrypsin. J. Biol. Chem. 277, 25486-25492.
57. 1-proteinase inhibitor. Methods Enzymol. 80, 754-765.
58. Johnson, D., and Travis, J. (1978) Structural evidence for methionine at the reactive site of human α-1-proteinase inhibitor. J. Biol. Chem. 253, 7142-7144.
59. 2-macroglobulin enzyme complexes. J. Clin. Invest. 52, 2175-2184.
60. 1-proteinase inhibitor. Am. J. Physiol. 266, L593-611.
61. 1-antitrypsin gene. Arterioscler. Thromb. Vasc. Biol. 23, 644-649.
62. 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc. Natl. Acad. Sci. U.S.A. 79, 2041-2045.
63. Ogushi, F., Hubbard, R. C.,Vogelmeier, C.,Fells, G. A., and Crystal, R. G. (1991) Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung α1-antitrypsin for neutrophil elastase. J. Clin. Invest. 87, 1060-1065.
64. Moraga, F., and Janciauskiene, S. (2000) Activation of primary human monocytes by the oxidized form of α1-antitrypsin. J. Biol. Chem 275, 7693-7700.
65. 1-antitrypsin and LDL. Arterioscler. Thromb. Vase. Biol. 21, 1801-1808.
66. Lim, A., Sengupta, S., McComb, M. E., Theberge, R., Wilson, W. G., Costello, C. E., and Jacobsen, D. W. (2003) In vitro and in vivo interactions of homocysteine with human plasma transthyretin. J. Biol. Chem. 278, 49707-49713.
67. Suhr, O. B., Ando, Y., Ohlsson, P. I., Olofsson, A., Andersson, K., Lundgren, E., Ando, M., and Holmgren, G. (1998) Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis. Eur. J. Clin. Invest. 28, 687-692.
68. Ando, Y., Nyhlin, N., Suhr, O., Holmgren, G., Uchida, K., el.Sahly, M., Yamashita, T., Terasaki, H., Nakamura, M., Uchino, M., and Ando, M. (1997) Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem. Biophys. Res. Commun. 232, 497-502.
69. Stone, P. J., CampistoL J. M., Abraham, C. R., Rodgers, O., Shirahama, T., and Skinner, M. (1993) Neutrophil proteases associated with amyloid fibrils. Biochem. Biophys. Res. Commun. 197, 130-136.
70. Schwarzman, A.L.,Gregori, L., Vitek, M.P., Lyubski, S.,Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J., Weisgraber, K. H., Coyle, P. K., Zagorski, M. G., Talafous, J., Eisenberg. M., Saunders, A. M., Roses, A. D., and Goldgaber, D. (1994) Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc. Natl. Acad. Sci. U.S.A. 91, 8368-8372.
71. Reynolds, W. F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R. A., and Masliah, E. (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155, 31-41.
72. Green, P. S., Mendez, A. J., Jacob, J. S., Crowley, J. R., Growdon, W., Hyman, B. T., and Heinecke, J. W. (2004) Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J Neurochem. 90, 724-733.